AJCC	American Joint Committee on Cancer
AI	Artificial intelligence
AMS	Atypical mole syndrome
BIN	BAP1-inactivated nevus
CDS	Cumulative solar damage
CLND	Complete lymph node resection
CNS	Central nervous system
ctDNA	Circulating tumor DNA
cTNM	Clinical stage group
CT Scan	Computed tomography
DPN	Deep penetrating nevus
FAMMM	Familial atypical multiple mole and melanoma
FISH	Fluorescence in situ hybridization
GEP	Gene expression profiling
HAV	Herpes simplex virus
IAMP	Intraepidermal atypical melanocytic proliferation
IAMPUS	Intraepidermal atypical melanocytic proliferation of uncertain significance
IMP	Intraepidermal melanocytic proliferation without atypia
LDH	Lactate dehydrogenase
LM	Lentigo maligna
LMM	Lentigo maligna melanoma
MAPK	Mitogen-activated protein kinase
MELTUMP	Melanocytic tumor of uncertain malignant potential
miRNAs	MicroRNAs
MIS	Melanoma in situ
MMS	Mohs micrographic surgery
MRI	Resonance imaging
NNMT	N-methyltransferase
PD-1	Programmed cell death protein 1
PD-L1	Programmed cell death-ligand 1
PET-CT	Positron emission tomography
PEM	Pigmented epithelioid melanocytoma
PI3K	Phosphatidyl inositol 3-kinase
PON2	Paraoxonase-2
pTNM	Pathological stage group
RGP	Radial growth phase
SLN	Sentinel lymph node
SLNB	Sentinel lymph node biopsy
SSM	Superficial spreading melanoma
STUMP	Spitzoid tumor of uncertain malignant potential
T-VEC	Talimogene laherparepvec
UV	Ultraviolet
VGP	Vertical growth phase
WHO	World Health Organization